Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

US approves sale of overdose reversal drug without prescription

The decision comes as a bid to widen access to the life-saving drug as the US struggles with a wave of overdose deaths.

Al Jazeera

Stay Forever Young With These 3 Pharmaceutical Stocks

Despite macroeconomic headwinds, the pharmaceutical industry is anticipated to stay buoyed in the foreseeable future, owing to rising healthcare spending. Against this backdrop, we think the strong fundamentals of Novo Nordisk (NVO), Bristol-Myers Squibb (BMY), and Takeda Pharmaceutical (TAK) make them wise portfolio additions. Read on….

StockNews.com

Quotient Sciences creates 100 new jobs fresh from multimillion-pound plant expansion

Recent expansion created an additional 80 to 100 new scientific and technical jobs at the facility - and now more have been created

Birmingham Post

From analysis to the latest developments in health,
read the most diverse news in one place.

3 of the Best Stocks in 1 of Wall Street's Worst-Rated Industry

After years of robust growth, the biotech industry has struggled since last year due to several headwinds, including regulatory concerns, inflation, and the Fed’s aggressive rate hikes, which have sucked out speculative capital. Despite currently being one of the poorly-rated industries, investors could consider buying top-biotech stocks Gilead (GILD), Vertex…

StockNews.com

3 Biotech Stocks Losing Momentum

As March comes to an end, biotech stocks Exelixis (EXEL), MacroGenics (MGNX), and Puma Biotechnology (PBYI) have been losing momentum. However, given the long-term prospects of the biotechnology industry and the administration’s push to boost domestic biomanufacturing, these biotech stocks could prove to be solid long-term investments. Read more.

StockNews.com

Urgent warning over pharmacy shortages of Calpol, Nurofen and other common drugs

Pharmacy chiefs have issued a warning over shortages of medicine cabinet essentials like Calpol, Nurofen as demand is higher than previous years - while the supply is lower

Daily Mirror

New female boss for Guinness giant Diageo

THE number of female bosses in the FTSE 100 is soon to hit double figures for the first time.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Dumfries and Galloway pharmaceutical workers set to be made redundant

Sixty-five jobs will be lost when Macfarlan Smith shuts its plant at Newbie

Daily Record

174 Liverpool jobs created by pharmaceutical giant after £151m boost

A further 156 roles have also been safeguarded

Liverpool Echo

Chinese pharmaceutical giant Pharmaron to create 174 Liverpool jobs after securing £151m investment

A total of £277m has been awarded through the grants

Birmingham Post

4 Medical Stocks That Could Help the Health of Investors’ Portfolios

The healthcare sector often fares well during difficult times due to the constant need for its goods and services. Therefore, quality medical stocks Novo Nordisk (NVO), AmerisourceBergen (ABC), Cardinal Health (CAH), and Haemonetics (HAE) might be the best investments for investors’ portfolios given current macroeconomic headwinds. Read on….

StockNews.com

IBD 50 Stocks To Watch: Vertex Pharmaceuticals Nears Buy Point; Institutions Scoop Up Shares

Vertex Pharmaceuticals is forming a base and back above its 50-day moving average. VRTX stock ranks third out of 792 biotechs.

Investors Business Daily

Novartis Surges As It Goes After Eli Lilly's Second Biggest Moneymaker

Novartis stock surged Monday after the company's treatment reduced the risk of relapse in patients with early-stage breast cancer.

Investors Business Daily

Eye drop recall 2023: The full list of brands that have been recalled

We share the full list of eye drop brands that have been recalled, after being linked to a rare strain of bacteria that can cause blindness and even death.

GoodToKnow

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

BioNTech Stock Crumbles After 2023 Outlook Misses By Almost $3 Billion

BioNTech said Monday it expects roughly $5.4 billion in sales of its Covid shot this year, missing views and leading BNTX stock to tumble.

Reason

Third Circuit Rejects Pacira Biosciences' Trade Libel Claim Over Article in Leading Medical Journal About EXPAREL

From Friday's Third Circuit decision in Pacira Biosciences, Inc. v. American Society of Anesthesiologists, Inc., written by Judge Patty Shwartz, joined by Judges Stephanos Bibas and Thomas Ambro: Pacira BioSciences, Inc. … sued the American Society of Anesthesiologists, Inc. …, the editor-in-chief of its medical journal, and the authors of…

Insider UK

Macfarlan Smith proposes Newbie facility closure

Around 65 jobs are at risk of redundancy at the south of Scotland pharmaceutical plant

The New Daily

Alan Kohler: Australia’s biotech sector has suddenly got much bigger

It wouldn’t take much of a nudge from the government to create a very vibrant and economically significant biotech industry.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Laughing gas ban ‘will not stop young people using it’, say experts

The Drug Science Scientific Committee also said a blanket ban on nitrous oxide was ‘completely disproportionate’ to the harms it caused.

StockNews.com

3 Large-Cap Pharma Stocks to Protect Your Portfolio Through 2023

The worst banking crisis since 2008 could not stop the Fed from raising the benchmark interest rate. The possibility of further policy tightening and strict lending standards for banks might push the economy into a recession this year. Therefore, investing in large-cap pharma stocks Johnson & Johnson (JNJ), Merck &…

The Independent UK

A blinding bacteria, four dead and an everyday brand blamed: What we know about the US eye drop recall

People have had to have their eyes surgically removed due to the bacteria

StockNews.com

2 Biotech Stocks to Buy Hand Over Fist in March

The biotech industry is expected to expand rapidly, driven by significant advancements and government initiatives. Furthermore, this sector tends to be relatively defensive and holds up relatively well during downturns. So, fundamentally sound biotech stocks Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) might be ideal buys now. Keep reading.

Reason

Law Restricting Pharmacist Speech About Ivermectin and Hydroxycholoroquine Likely Violates the First Amendment

A federal judge issued a preliminary injunction against the enforcement of the law.

Los Angeles Times

LA Sheriff's Department saw signs of deadly street drug 4 years ago, told health officials about it this month

LOS ANGELES — It was at least four years ago that Los Angeles County Sheriff’s Department officials say they began finding signs of a dangerous sedative infiltrating the local drug supply.

The Independent UK

Senators press Moderna CEO on COVID-19 vaccine price hike

Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price

1 … 46 47 48 49

People

Bernie Sanders

1,217 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.